| Bioactivity | Oxcarbazepine-d8-1 is a deuterium of Oxcarbazepine. Oxcarbazepine is a sodium channel blocker[1]. Oxcarbazepine significantly inhibits glioblastoma cell growth and induces apoptosis or G2/M arrest in glioblastoma cell lines[2]. Oxcarbazepine? has anti-cancer and anticonvulsant effects[2]. |
| Name | Oxcarbazepine-d8 |
| CAS | 1261396-65-9 |
| Formula | C15H4D8N2O2 |
| Molar Mass | 260.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ashley M Thomas, et al. Old Friends With New Faces: Are Sodium Channel Blockers the Future of Adjunct Pain Medication Management?J Pain. 2018 Jan;19(1):1-9. [2]. Ching-Yi Lee,et al. The effects of antiepileptic drugs on the growth of glioblastoma cell lines. J Neurooncol. 2016 May;127(3):445-53. |
Oxcarbazepine-d8
CAS: 1261396-65-9 F: C15H4D8N2O2 W: 260.32
Oxcarbazepine-d8-1 is a deuterium of Oxcarbazepine. Oxcarbazepine is a sodium channel blocker. Oxcarbazepine significant
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.